24 Oct 2022 Bionest A New Advance in the Treatment of Major Depressive Disorder Could the FDA approval of Auvelity usher in a new class of antidepressants? The new oral treatment for depression works with the glutamate receptor NMDA.
10 Oct 2022 Bionest Are the Blues Ending for Bluebird? Gene therapy developer bluebird bio may be turning a corner, with recent FDA approvals for two of its rare disease therapeutics.